Navigation Links
Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 Second Quarter Results
Date:7/21/2009

                          Wednesday, August 5, 2009
                                9:00 a.m. EDT

                               1-800-731-5774

                Webcast:http://www.nucryst.com/web_casts.htm

PRINCETON, NJ, July 21 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. invites analysts and investors to participate in a briefing on Wednesday, August 5, with David B. Holtz, Interim President Chief Executive Officer, and Chief Financial Officer, regarding the Company's 2009 second quarter results.

The briefing, via conference call, is set for 9:00 a.m. EDT. To participate, please call the toll-free number 1-800-731-5774. In addition to standard disclosure over wire services, a news release with the second quarter results will be posted on the NUCRYST web site prior to the call. To listen to the call live on the Internet, please go to http://www.nucryst.com/web_casts.htm.

The briefing will be recorded and available for re-broadcast on demand for seven days by dialing 1-877-289-8525. Callers will need to provide the operator with the following reservation number: 21309904 followed by the number sign. An audio file of the call will also be archived on the NUCRYST web site.

About NUCRYST Pharmaceuticals

NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using SILCRYST(TM), its patented atomically disordered nanocrystalline silver technology. NUCRYST licensed world-wide rights for SILCRYST(TM) wound care coating products to Smith Nephew plc, which markets these products in over 30 countries under their Acticoat(TM) trademark. NUCRYST has developed its proprietary nanocrystalline silver in a powder form, referred to as NPI 32101, for use in medical devices and as an active pharmaceutical ingredient.

    Acticoat(TM) is a trademark of Smith & Nephew plc
    SILCRYST(TM) is a trademark of NUCRYST Pharmaceuticals Corp.


'/>"/>
SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009
2. Weight Watchers Announces Second Quarter 2009 Earnings Conference Call
3. STERIS Corporation Announces Date of Fiscal 2010 First Quarter Earnings Release and Conference Call
4. Feel Fun, Fit & Fabulous! At the 2009 Womens Health Conference
5. Scholarships Available for PA Breast Cancer Coalition Annual Conference
6. Echo Therapeutics to Present at Jessup & Lamont 2009 Growth Stock Conference
7. Interaction Associates and The Interaction Institute for Social Change Present at the Greater Than Conference
8. Reminder - Human Genome Sciences to Host Conference Call to Discuss Top-Line Phase 3 Results for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Systemic Lupus Erythematosus
9. Pelosi House Leaders, Committee Chairs Remarks at Press Conference on Americas Affordable Health Choices Act
10. Reed Group Will Debut New Predictive Modeling Tool at DMEC Conference
11. NHP Announces Second Quarter Earnings Release Date and Webcast/Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
(Date:10/4/2017)... SEOUL, South Korea , Oct. 4, 2017 /PRNewswire/ ... launched its next-generation CPR training aide "cprCUBE" on Kickstarter. ... of chest compression during cardiac arrests with better efficiency ... patient-mannequins. It also offers real-time feedback on efficacy of ... The crowdfunding campaign has a goal to raise ...
Breaking Medicine Technology: